We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Although Chinese pharmaceuticals, especially traditional Chinese medicine, sell like hot cakes on the global market with rapid growth in exports, there are still challenges, according to customs insiders from Fuzhou, capital of East China's Fujian Province.
New York-based Pfizer will sell its consumer healthcare division to Johnson & Johnson (J&J) for $16.6 billion and focus on developing new drugs and acquiring new technology, according to announcements by both companies.
Drugmaker Barr Pharmaceuticals has announced that the supervisory board of Croatia-based Pliva has endorsed Barr's proposal to make a tender offer to Pliva's shareholders to purchase 100% of the shares of the company for approximately $2.2 billion in cash.
Japan's Teijin Pharma and Sato Pharmaceutical will begin marketing Bonalfa lotion (tacalcitol), an ethical agent for treating psoriasis vulgaris, the companies announced.
Banyu Pharmaceutical recently published the results of the Japan Lipid Intervention Trial (J-LIT), large-scale clinical trials of LIPOVAS, its proprietary anti-hyperlipidemic agent, in Circulation Journal, an academic and professional publication of the Japanese Circulation Society.
Celera Genomics, an Applera Corporation business, and Medarex Inc. have entered into a collaboration to discover and develop human antibodies for the potential treatment of multiple cancer indications.
Eli Lilly and Company announced today that its Board of Directors has declared a dividend for the third quarter of 2006 of 40 cents a share on outstanding common stock.
AstraZeneca, a major British pharmaceutical company, has said it intends to broaden joint research endeavors with South Korean labs, industry sources said Monday.
Hadasit Bio Holdings Ltd. today announced that portfolio company TK Signal Ltd. raised $1.3 million form London investors at a company value of $10 million, before money.